Knowledge Hub
Categories:
- Allergy [1]
- Antimicrobials & infection [5]
- Autoimmune [1]
- Chemical Pathology [15]
- Endocrinology [1]
- Epidemiology [3]
- Gastrointestinal [2]
- Genetics [6]
- Genitourinary [2]
- Haematology [9]
- HIV/TB [3]
- Infectious Diseases [10]
- Neurology [4]
- Obstetric and Neonatal care [4]
- Oncology [1]
- Ophthalmology [1]
- Respiratory [2]
- Serology [3]
- Virology [44]
With regard to Designated Service Provider (DSP) Contracts the following law is pertinent for service providers who are not a DSP:
- In terms of Section 59 (2) of the Medical Schemes Act 131 of 1998 the medical scheme must pay valid invoices within 30 days of receipt thereof or advise both the member and service provider of reasons why the invoice is not valid and provide the opportunity to correct the invoice.
- Where services are in respect of medical emergencies or involuntarily obtained services for PMB conditions, the scheme has to pay for the full cost of the services provided without deduction or co-payment or limiting the tariff amount. (Regulation 8 (1) of the Medical Schemes Act no. 131 of 1998.)
- DOH notice 214 of 2021 requires that a scheme pays for services provided at the same rate and in terms of the same rules as they pay their DSPs in respect of services voluntarily obtained, whether they are PMBs or not.
- The process followed in respect of appointing a DSP is required to be fair, equitable, transparent, competitive or cost effective as required in terms of Notice 214 of the DOH.
In summary:
- The law protects the patient’s choice to use their laboratory of choice, even if it is not a DSP, and the scheme is still obliged to reimburse us at the scheme rate for valid claims.
- This is true for PMB conditions as well as non-PMB conditions.
- The medical scheme must pay valid invoices within 30 days or advise both the member and service provider of reasons why the invoice is not valid and provide the opportunity to correct invoice.
- A scheme must pay for the services provided at a tariff not less than what they would pay a DSP.
- Should any patient have a valid claim rejected because we are not a DSP, we can assist.
CKD- EPI Formula
The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) study group developed this formula in 2009, find out more about what the formula is, drug dosing and its limitations in this downloadable pdf. CKD - EPI Formula PDF
Cervical Screening Recommendations
In this downloadable pdf you can find Cervical Screening Recommendations adopted from ACS, AGOG, ASCCP updated guidelines 2013. For the complete ASCCP updated Consensus Guidelines on Management of Women with Abnormal Cervical Cancer Screening tests go to:...
Bethesda Reporting System Update for Gynaecological Cytology
PathCare uses the Bethesda system (TBS) for the reporting of cervical Cytology specimens. You can view the changes and recommendations that were introduced in 2014 in this downloadable pdf.
Antibiotics: What patients should know
Antibiotics save lives, but bacterial resistance to antibiotics is on the rise. There are concerns that antibiotics may soon loose their ability to cure. Find out the important facts about antibiotics, getting better without antibiotics and when antibiotics are...
Antibiotic Awareness Week
Antibiotic resistance is one of the biggest threats to global health today. View more information in this downloadable pdf on World Antibiotic Awareness Week to increase awareness of the problem of antibiotic resistance and encourage best practices to avoid further...